These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19804967)

  • 1. The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.
    Moon CM; Bang S; Chung JB
    Surg Oncol; 2011 Mar; 20(1):e10-7. PubMed ID: 19804967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
    Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
    J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.
    Kluge R; Schmidt F; Caca K; Barthel H; Hesse S; Georgi P; Seese A; Huster D; Berr F
    Hepatology; 2001 May; 33(5):1029-35. PubMed ID: 11343227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
    Kim YJ; Yun M; Lee WJ; Kim KS; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1467-72. PubMed ID: 14579085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
    Corvera CU; Blumgart LH; Akhurst T; DeMatteo RP; D'Angelica M; Fong Y; Jarnagin WR
    J Am Coll Surg; 2008 Jan; 206(1):57-65. PubMed ID: 18155569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.
    Ruys AT; Bennink RJ; van Westreenen HL; Engelbrecht MR; Busch OR; Gouma DJ; van Gulik TM
    HPB (Oxford); 2011 Apr; 13(4):256-62. PubMed ID: 21418131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
    Parikh U; Marcus C; Sarangi R; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):327-43. PubMed ID: 26099670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
    Buchmann I; Ganten TM; Haberkorn U
    Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis.
    Hu JH; Tang JH; Lin CH; Chu YY; Liu NJ
    J Investig Med; 2018 Jan; 66(1):52-61. PubMed ID: 28912249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance and Prognostic Relevance of FDG Positron Emission Tomography/Computed Tomography for Patients with Extrahepatic Cholangiocarcinoma.
    Kim NH; Lee SR; Kim YH; Kim HJ
    Korean J Radiol; 2020 Dec; 21(12):1355-1366. PubMed ID: 32767862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
    Kato T; Tsukamoto E; Kuge Y; Katoh C; Nambu T; Nobuta A; Kondo S; Asaka M; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1047-54. PubMed ID: 12173019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F-FDG PET/CT in staging and restaging cholangiocarcinoma].
    Notaristefano A; Niccoli Asabella A; Stabile Ianora AA; Merenda N; Moschetta M; Antonica F; Altini C; Ferrari C; Cesarano E; Rubini G
    Recenti Prog Med; 2013; 104(7-8):328-35. PubMed ID: 24042402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma: A meta-analysis.
    Huang X; Yang J; Li J; Xiong Y
    Medicine (Baltimore); 2020 Aug; 99(35):e20932. PubMed ID: 32871859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma.
    Seo S; Hatano E; Higashi T; Nakajima A; Nakamoto Y; Tada M; Tamaki N; Iwaisako K; Mori A; Doi R; Ikai I; Uemoto S
    Surgery; 2008 Jun; 143(6):769-77. PubMed ID: 18549893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
    Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM
    AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
    Park MS; Lee SM
    Anticancer Res; 2014 May; 34(5):2551-4. PubMed ID: 24778075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.
    Petrowsky H; Wildbrett P; Husarik DB; Hany TF; Tam S; Jochum W; Clavien PA
    J Hepatol; 2006 Jul; 45(1):43-50. PubMed ID: 16690156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET in the diagnosis of hilar cholangiocarcinoma.
    Fritscher-Ravens A; Bohuslavizki KH; Broering DC; Jenicke L; Schäfer H; Buchert R; Rogiers X; Clausen M
    Nucl Med Commun; 2001 Dec; 22(12):1277-85. PubMed ID: 11711897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.